NeOnc Technologies Holdings, Inc. (NTHI)
8.73
+0.03
(+0.34%)
USD |
NASDAQ |
Jan 16, 16:00
8.76
+0.03
(+0.34%)
After-Hours: 20:00
NeOnc Technologies Holdings Research and Development Expense (Quarterly): 0.715M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Synergy CHC Corp. | -- |
| Lantern Pharma, Inc. | 2.437M |
| NRX Pharmaceuticals, Inc. | 1.429M |
| Acurx Pharmaceuticals, Inc. | 0.4297M |
| CEL-SCI Corp. | 3.703M |